EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENTExclusive Manufacturing, Supply and Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2013 Company Industry JurisdictionThis EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of 5:00 PM Eastern Daylight Time, August 23, 2010 (the “Effective Date”) by and between Kamada Ltd., an Israeli corporation (collectively with its Affiliates, “Kamada”), whose principal office is at Science Park, Kiryat Weizmann, 7 Sapir Street, P.O. Box 4081, Ness Ziona 74140, Israel, and Baxter Healthcare Corporation (“Baxter”), a Delaware corporation whose principal office is at One Baxter Parkway, Deerfield, Illinois 60015, USA.
THIRD AMENDMENT TO THE EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENTExclusive Manufacturing, Supply and Distribution Agreement • April 28th, 2015 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledApril 28th, 2015 Company IndustryThis Third Amendment to the Exclusive Manufacturing, Supply and Distribution Agreement dated August 23rd, 2010 as amended on September 6th, 2012, and May 14th, 2013, by and between Baxter Healthcare Corporation having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “Baxter”) and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “Kamada”) (the "Agreement") is entered into as of this 15th day of February, 2014 (the "Effective Date"). Baxter and Kamada shall collectively be referred to as the “Parties”.
September 6, 2012 Kamada Ltd. Science Park Kiryat WeizmannExclusive Manufacturing, Supply and Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledMay 15th, 2013 Company Industry
FIFTH AMENDMENT TO THE EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENTExclusive Manufacturing, Supply and Distribution Agreement • March 1st, 2017 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledMarch 1st, 2017 Company IndustryThis FIFTH Amendment to the Exclusive Manufacturing, Supply and Distribution Agreement dated August 23rd, 2010 as amended on September 6th, 2012, May 14th, 2013, February 15th, 2014, and August 25th, 2015, by and between Baxalta US Inc., now part of Shire, having a place of business at 1200 Lakeside Dr., Bannockburn, IL 60060 (hereinafter "Baxalta") and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter "Kamada") (the "Agreement") is entered into as of this 10th day of August, 2016 (the "Effective Date"). Baxalta and Kamada shall collectively be referred to as the "Parties".
SECOND AMENDMENT TO THE EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENTExclusive Manufacturing, Supply and Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledMay 15th, 2013 Company IndustryThis Second Amendment to the Exclusive Manufacturing, Supply and Distribution Agreement dated August 23rd, 2010 as amended on September 6th, 2012 by and between Baxter Healthcare Corporation having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “Baxter”) and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “Kamada”) (the "Agreement") is entered into as of this 14th day of May, 2013 (the "Effective Date"). Baxter and Kamada shall collectively be referred to as the “Parties”.
FOURTH AMENDMENT TO THE EXCLUSIVE MANUFACTURING, SUPPLY AND DISTRIBUTION AGREEMENTExclusive Manufacturing, Supply and Distribution Agreement • February 25th, 2016 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledFebruary 25th, 2016 Company IndustryThis FOURTH Amendment to the Exclusive Manufacturing, Supply and Distribution Agreement dated August 23rd, 2010 as amended on September 6th, 2012, May 14th, 2013, and February 15, 2014 by and between Baxalta US Inc., having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “Baxalta”) and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “Kamada”) (the "Agreement") is entered into as of this 10th day of August, 2015 (the "Effective Date"). Baxalta and Kamada shall collectively be referred to as the “Parties”.
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. [*****] indicates the redacted confidential portions of this...Exclusive Manufacturing, Supply and Distribution Agreement • February 26th, 2020 • Kamada LTD • Pharmaceutical preparations
Contract Type FiledFebruary 26th, 2020 Company IndustryThis SIXTH Amendment to the Exclusive Manufacturing, Supply and Distribution Agreement dated August 23rd, 2010 as amended on September 6th, 2012, May 14th, 2013, February 15th, 2014, August 25th, 2015, and September 30th, 2016, by and between Baxalta US Inc., a member of the Takeda group of companies, having a place of business at 1200 Lakeside Dr., Bannockburn, IL 60015, USA (hereinafter “Baxalta”) and Kamada Ltd., having a place of business at 2 Holzman Street, Weizmann Science Park, Rehovot 7670402, Israel (hereinafter “Kamada”) (the “Agreement”) is entered into as of this 30th day of August, 2019 (the “Effective Date”). Baxalta and Kamada shall collectively be referred to as the “Parties”.